|
Mr. Howard has over 25 years of experience in technology and hi-growth business development and has served on several boards and advisory councils for business and charitable organizations. He is principal of Whitesand Investments LLC an angel investment organization that operates as a traditional venture fund.
In 1990 he founded and served as CEO and Chairman of Phyton Inc. a world leader in the use of proprietary plant cell fermentation technology including the production of paclitaxel the active ingredient of Bristol-Myers Squibb's multi-billion dollar anticancer drug Taxol®. Phyton was sold to DFB Pharmaceuticals Inc. in 2003.
Additionally Mr. Howard is the Chairman of DeepGulf Inc. and a co-owner and officer of Silver Bullet Technology. DeepGulf builds underwater pipelines and associated facilities in deep and ultra-deep offshore oil and gas production fields. Silver Bullet Technology where he has been primarily responsible for corporate and financial oversight as well as strategic planning manufactures and sells software for the banking and payment processing industry. Previously he served as president and CEO of BioWorks Inc. a biotechnology company he founded to develop produce and sell products that replace chemical pesticides.
He earned his MBA from Cornell University's Johnson Graduate School of Management where he focused his studies on Entrepreneurship and managing innovation and technology.
As a member of the New York Biotechnology Association he served as the federal liaison for the government affairs committee of the New York Biotechnology Association and Biotechnology Industry Organization (BIO). He serves on several boards including the Belmont Art Center the Pensacola Opera and was formerly on the board of the Make-A-Wish Foundation of Northwest Florida. | 